Answer
Yes, Jakavi (ruxolitinib phosphate) can cause anaemia, which may require blood transfusions, dose modifications or treatment interruption.
Sources for this answer
- Jakavi 5mg, 10mg, 15mg and 20mg TabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 29Document updated
Sources checked